Effects of SGLT2 selective inhibitor ipragliflozin on hyperglycemia, hyperlipidemia, hepatic steatosis, oxidative stress, inflammation, and obesity in type 2 diabetic mice

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

European Journal of Pharmacology

Topics

Medicine

Internal Medicine

Endocrinology

Surgery

Endocrinology, Diabetes And Metabolism

Show all topics

DOI

10.1016/j.ejphar.2013.05.014